caa a22 4500 465738915 CHVBK 20180323111803.0 cr unu---uuuuu 170327e19900301xx s 000 0 eng 10.1007/BF02244607 doi (NATIONALLICENCE)springer-10.1007/BF02244607 High versus low-dose piracetam in alcohol organic mental disorder: a placebo controlled study [Elektronische Daten] [C. Barnas, C. Miller, H. Ehrmann, P. Schett, V. Günther, W. Fleischhacker] A marked tendency to increase the dose of piracetam in the treatment of organic mental disorder can be observed in clinical practice. A placebo controlled study comparing two doses (i.e. 6 g and 24 g per die) was performed to evaluate the benefits of high dose piracetam in the treatment of organic mental disorder of chronic alcohol addicts. 60 inpatients participated in the study. Cognitive impairment was verified by various psychological tests on day 0; patients were also evaluated on days 7, 14, 28 and 42 of the trial. While the patients of all three groups showed a significant amelioration during the treatment period, a modest but significant superiority was indicated for the high piracetam dose. There was no difference between the placebo group and the patients receiving low dose piracetam. Springer-Verlag, 1990 Piracetam nationallicence Efficacy nationallicence Dose nationallicence Alcoholism nationallicence Organic mental disorder nationallicence Cognitive impairment nationallicence Barnas C. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Miller C. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Ehrmann H. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Schett P. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Günther V. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Fleischhacker W. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut Psychopharmacology Springer-Verlag 100/3(1990-03-01), 361-365 0033-3158 100:3<361 1990 100 213 https://doi.org/10.1007/BF02244607 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02244607 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Barnas C. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 700 1- Miller C. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 700 1- Ehrmann H. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 700 1- Schett P. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 700 1- Günther V. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 700 1- Fleischhacker W. Biological Psychiatry Research Unit, Department of Psychiatry, Innsbruck University Hospital, Anichstrasse 35, A-6020, Innsbruck, Austria aut NATIONALLICENCE 773 0- Psychopharmacology Springer-Verlag 100/3(1990-03-01), 361-365 0033-3158 100:3<361 1990 100 213 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer